Filter:AllMonitoringDiagnosisComplicationsType 1Type 2
The FDA has authorized Libre Duo 10 Day for people aged 2 and older with diabetes. Here is how combined continuous glucose and ketone monitoring works, what the evidence shows, and the DKA safety limits patients should understand.
A randomized trial found that adding flash glucose monitoring did not improve glycaemic control in gestational diabetes, while a secondary newborn finding needs cautious interpretation.
